FOXA1 and neoplasm: Other potential underlying biological causes for ARBS heterogeneity include pioneer factor FOXA1 mutations that alter its cistrome55–57, disease stage-specific epigenetic states (either induced by therapy or not)4,5,58, and clonal heterogeneity arising from tumor multifocality59,60.